1. Home
  2. ITOS vs BRY Comparison

ITOS vs BRY Comparison

Compare ITOS & BRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • BRY
  • Stock Information
  • Founded
  • ITOS 2011
  • BRY 1909
  • Country
  • ITOS United States
  • BRY United States
  • Employees
  • ITOS N/A
  • BRY N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • BRY Oil & Gas Production
  • Sector
  • ITOS Health Care
  • BRY Energy
  • Exchange
  • ITOS Nasdaq
  • BRY Nasdaq
  • Market Cap
  • ITOS 342.6M
  • BRY 397.0M
  • IPO Year
  • ITOS 2020
  • BRY N/A
  • Fundamental
  • Price
  • ITOS $8.32
  • BRY $4.23
  • Analyst Decision
  • ITOS Strong Buy
  • BRY Hold
  • Analyst Count
  • ITOS 3
  • BRY 1
  • Target Price
  • ITOS $33.67
  • BRY $5.00
  • AVG Volume (30 Days)
  • ITOS 543.4K
  • BRY 1.5M
  • Earning Date
  • ITOS 11-12-2024
  • BRY 11-07-2024
  • Dividend Yield
  • ITOS N/A
  • BRY 11.58%
  • EPS Growth
  • ITOS N/A
  • BRY 73.42
  • EPS
  • ITOS N/A
  • BRY 1.06
  • Revenue
  • ITOS $35,000,000.00
  • BRY $806,733,000.00
  • Revenue This Year
  • ITOS $271.18
  • BRY N/A
  • Revenue Next Year
  • ITOS N/A
  • BRY $0.80
  • P/E Ratio
  • ITOS N/A
  • BRY $3.98
  • Revenue Growth
  • ITOS N/A
  • BRY N/A
  • 52 Week Low
  • ITOS $7.54
  • BRY $4.10
  • 52 Week High
  • ITOS $18.75
  • BRY $8.88
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 39.51
  • BRY 33.50
  • Support Level
  • ITOS $7.54
  • BRY $4.10
  • Resistance Level
  • ITOS $8.38
  • BRY $4.34
  • Average True Range (ATR)
  • ITOS 0.53
  • BRY 0.27
  • MACD
  • ITOS 0.01
  • BRY -0.04
  • Stochastic Oscillator
  • ITOS 35.94
  • BRY 7.22

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About BRY Berry Corporation (bry)

Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.

Share on Social Networks: